Immune checkpoint crosstalk: CTLA-4/CD80 engagement as a predictor of anti-PD-1/PD-L1 therapy outcome in NSCLC. [PDF]
Gumuzio J +10 more
europepmc +1 more source
The Prognostic Role of CD8+ Tumor‐Infiltrating Lymphocyte Density in Head and Neck Mucosal Melanoma
Abstract Objective To explore the prognostic role of CD8+ tumor‐infiltrating lymphocytes (TIL) density in head and neck mucosal melanoma (HNMM) using an automated, quantitative, immunohistochemistry‐based methodology. Study Design Retrospective cohort study. Setting Single‐institution, tertiary care hospital.
Nicholas K. Fung +3 more
wiley +1 more source
Nanocarrier-Mediated Immunotherapy for Gynecological Malignancies: Mechanisms, Clinical Translation, and Emerging Nucleic Acid-Based Strategies. [PDF]
Fu M +5 more
europepmc +1 more source
Melittin Reprograms Tumor‐Associated Macrophages Through CD18‐Mediated Immunomodulation
Melittin selectively targets CD18 to deplete M2‐TAMs and remodel the TME to suppress tumor growth. ABSTRACT Tumor‐associated macrophages (TAMs), particularly the M2‐like subtype, contribute to an immunosuppressive tumor microenvironment and promote tumor progression.
Ik‐Hwan Han +6 more
wiley +1 more source
Catechins and Their Effect on the Gut Microbiome in Health and Cancer
ABSTRACT Catechins are a group of flavonoids found primarily in green tea, fruits, and berries; they play a significant role in the modulation of the gut microbiota, thereby having an impact on gut health and cancer prevention. Owing to their low bioavailability, catechins are transformed by the gut microbiota into various bioactive metabolites such as
Prakash Monika +5 more
wiley +1 more source
Correlation between NRS-2002 scores and PD-1/CTLA-4 expression levels in patients with community-acquired pneumonia. [PDF]
Zhang C +7 more
europepmc +1 more source
Co-stimulatory signal deficiency impairs cytotoxic T lymphocyte function in tumor immune evasion: molecular mechanisms and therapeutic implications. [PDF]
Ma J +6 more
europepmc +1 more source
Immune Responses in Checkpoint Inhibitor-Associated Cardiovascular Immune-Related Adverse Events: JACC: CardioOncology State-of-the-Art Review. [PDF]
Reynolds KL +13 more
europepmc +1 more source

